India to Iraq: Actinomycin Export Trade Route
India has recorded 26 verified shipments of Actinomycin exported to Iraq, representing a combined trade value of $21.1K USD. This corridor is served by 12 active Indian exporters, with an average shipment value of $811 USD. The leading Indian exporter is CHANDRA BHAGAT PHARMA LIMITED, which accounts for 74% of total export value with 1 shipments worth $15.6K USD. On the buying side, TO THE ORDER is the largest importer in Iraq with $15.6K USD in purchases. The top 3 suppliers — CHANDRA BHAGAT PHARMA LIMITED, RAVI PHARMA, DISTINCT IMPEX PRIVATE LIMITED — together control 90% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Iraq Actinomycin corridor is one of India's established pharmaceutical export routes, with 26 shipments documented worth a combined $21.1K USD. The route is dominated by CHANDRA BHAGAT PHARMA LIMITED, which alone accounts for roughly 74% of all export value, reflecting the consolidated nature of India's actinomycin manufacturing sector.
Across 12 active suppliers, the average shipment value stands at $811 USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 80% of all shipments, consistent with actinomycin's non-urgent bulk-order profile.
Shipment activity peaks during April–June, with an average transit time of 20 days port-to-port. The route has recorded an annual growth rate of 16.7%, placing it at rank #16 among India's top actinomycin export destinations globally.
On the import side, key buyers of Indian actinomycin in Iraq include TO THE ORDER, SKIN LINE LOGISTIC, NA and 9 others. TO THE ORDER is the single largest importer with 1 shipments valued at $15.6K USD.
